$STLT will report even massive earnings soon!!! Stock is testing the last lows, low volume forgotten biotech start up that has its first product now on Walmart store shelves and cobra venom based rub on pain killer for chronic pain targeting opioid addition!!!

Last 10-Q was not impressive, showed $1000 in sales and $500,000 in inventory (and debt), the next 10-Q could be a blow out revenue number no one is watching for yet!!!! They have Cancer drug trials under way..